Evidence map›Paper›PMID 23055928›Full record

ArticlePLoS pathogens2012

Evolutionary history and attenuation of myxoma virus on two continents.

Peter J Kerr, Elodie Ghedin, Jay V DePasse, Adam Fitch, Isabella M Cattadori, Peter J Hudson, David C Tscharke, Andrew F Read, Edward C Holmes

Abstract read
In one paragraph

Article in PLoS pathogens, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Peter J KerrCSIRO Ecosystem Sciences, Canberra, Australian Capital Territory, Australia.
Elodie Ghedin
Jay V DePasse
Adam Fitch
Isabella M Cattadori
Peter J Hudson
David C Tscharke
Andrew F Read
Edward C Holmes

Funding

Genomic analysis of the canonical case of virulence evolution: Myxomatosis in AuR01AI093804 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI READ, ANDREW F. · 2012 to 2016
$2.7M
NIAID NIH HHS R01 AI093804NIAID NIH HHS R01 AI093804-01A1
6 · The paper itself

Abstract

The attenuation of myxoma virus (MYXV) following its introduction as a biological control into the European rabbit populations of Australia and Europe is the canonical study of the evolution of virulence. However, the evolutionary genetics of this profound change in host-pathogen relationship is unknown. We describe the genome-scale evolution of MYXV covering a range of virulence grades sampled over 49 years from the parallel Australian and European epidemics, including the high-virulence progenitor strains released in the early 1950s. MYXV evolved rapidly over the sampling period, exhibiting one of the highest nucleotide substitution rates ever reported for a double-stranded DNA virus, and indicative of a relatively high mutation rate and/or a continually changing selective environment. Our comparative sequence data reveal that changes in virulence involved multiple genes, likely losses of gene function due to insertion-deletion events, and no mutations common to specific virulence grades. Hence, despite the similarity in selection pressures there are multiple genetic routes to attain either highly virulent or attenuated phenotypes in MYXV, resulting in convergence for phenotype but not genotype.

Indexed as

Evolution, MolecularGenome, ViralAnimalsAustraliaBase SequenceBiological EvolutionDNA, ViralEuropeMolecular Sequence DataMutation RateMyxomatosis, InfectiousMyxoma virusPhylogenyRabbitsSequence Analysis, DNADNA, Viral

Identifiers

PMID23055928
PMCPMC3464225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.